Acusensus (ASX:ACE) Accounts Payable & Accrued Expense: A$13.17 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:ACE Acusensus Ltd ASX:ACE
40 GF Score
Price A$1.23
GF Value A$1.43
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Acusensus Accounts Payable & Accrued Expense?

Acusensus ASX:ACE -1.21% 40 Accounts Payable & Accrued Expense is A$13.17 Mil as of Jun. 2026. GuruFocus rates ASX:ACE with a GF Score™ of 40/100 and a GF Value™ of A$1.43 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Acusensus's quarterly accounts payable & accrued expense increased from Jun. 2025 (A$8.16 Mil) to Dec. 2025 (A$8.40 Mil) and increased from Dec. 2025 (A$8.40 Mil) to Jun. 2026 (A$13.17 Mil).

Acusensus's annual accounts payable & accrued expense increased from Jun. 2024 (A$6.00 Mil) to Jun. 2025 (A$8.16 Mil) and increased from Jun. 2025 (A$8.16 Mil) to Jun. 2026 (A$13.17 Mil).

Acusensus Accounts Payable & Accrued Expense Historical Data

* Premium members only.

The historical data trend for Acusensus's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acusensus Accounts Payable & Accrued Expense Chart

Acusensus Annual Data
Trend Jun22 Jun23 Jun24 Jun25 Jun26
Accounts Payable & Accrued Expense
5.94 5.83 6.00 8.16 13.17

Acusensus Semi-Annual Data
Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Accounts Payable & Accrued Expense Get a 7-Day Free Trial 6.00 7.67 8.16 8.40 13.17
ASX:ACE
40GF Score
Acusensus Ltd ASX:ACE
Accounts Payable & Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Acusensus Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

What does a Accounts Payable & Accrued Expense of A$13.17 Mil mean?
Acusensus (ASX:ACE) has a Accounts Payable & Accrued Expense of A$13.17 Mil as of Jun. 2026. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on Acusensus and its competitors.
Is Acusensus' Accounts Payable & Accrued Expense too high?
Acusensus' current Accounts Payable & Accrued Expense is A$13.17 Mil. Overall, Acusensus has a GF Score™ of 40/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Acusensus' Accounts Payable & Accrued Expense compare to MSFT and PLTR?
Acusensus' Accounts Payable & Accrued Expense of A$13.17 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable & Accrued Expense for a Software company?
A good Accounts Payable & Accrued Expense depends on the Software industry context. However, Accounts Payable & Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable & Accrued Expense mean?
A high Accounts Payable & Accrued Expense can signal that a stock is expensive relative to its fundamentals. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on Acusensus and its competitors. Acusensus's current Accounts Payable & Accrued Expense is A$13.17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acusensus stock overvalued right now?
Based on GuruFocus' analysis, Acusensus (ASX:ACE) is currently considered Modestly Undervalued. The stock's GF Value™ is A$1.43, compared to a current price of A$1.23 — trading 14.3% below its estimated fair value. The current Accounts Payable & Accrued Expense is A$13.17 Mil. Acusensus' overall GF Score™ is 40/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable & Accrued Expense calculated?
Accounts Payable & Accrued Expense is calculated from a company's financial statements. For Acusensus (ASX:ACE), the current Accounts Payable & Accrued Expense is A$13.17 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Acusensus (ASX:ACE) Overvalued in 2026?

Based on GuruFocus' analysis, Acusensus stock appears to be undervalued. The current stock price of A$1.23 is trading 14.3% below its estimated GF Value™ of A$1.43. GuruFocus considers Acusensus to be Modestly Undervalued.

Key valuation signals for ASX:ACE:

  • Accounts Payable & Accrued Expense: A$13.17 Mil
  • GF Value™: A$1.43 vs. price of A$1.23 (14.3% below fair value)
  • GF Score™: 40/100 with 1 warning sign

No single metric tells the full story. See the ASX:ACE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Acusensus Business Description

Address 31 Queen Street, Level 1, Melbourne, VIC, AUS, 3000
Acusensus Ltd is involved in developing and commercializing intelligent traffic solutions technology. Its 'Heads-Up' solution has been designed to give authorities a tool to address distraction and other illegal driver behavior, to drive behavioral change on the road network. It also provides Data security solutions. The company's main objective is to Pioneer intelligent solutions to tackle difficult societal challenges, reduce road trauma and save lives. Geographically the company generates the majority of its revenue from Australia.
40GF Score

Get the complete analysis for ASX:ACE

Accounts Payable & Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.23
Price
A$1.43
GF Value